PharmaCielo (TSE:PCLO) has released an update.
PharmaCielo, a Canadian-based global medical cannabis company, has announced a change in its financial year-end to align with industry peers and appointed Davidson & Company LLP as its new auditor. The company’s financial year will now end on March 31, with a transitional report covering a fifteen-month period to be released, while Davidson’s regional experience is expected to enhance audit oversight.
For further insights into TSE:PCLO stock, check out TipRanks’ Stock Analysis page.
